Insmed Incorporated Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio33.9614.5311.0317.1120.63
P/B Ratio43.28-13.3630.787.8612.29
Price/Tangible Book104.2313.2712.38
Enterprise Value Ratios
EV/Revenue33.1116.3812.3215.8119.48
Profitability & Returns
Return on Equity (ROE)-1.93%-1.27%-1.09%
Return on Assets (ROA)-0.29%-0.28%-0.21%-0.23%-0.22%
Return on Capital Employed (ROCE)-0.46%-0.62%-0.33%-0.33%-0.39%
Leverage & Solvency Ratios
Debt/Equity4.59-4.0915.071.491.47
Liquidity Ratios
Current Ratio5.454.126.696.195.24
Quick Ratio4.993.646.195.484.62
Efficiency Ratios
Asset Turnover0.220.200.170.180.21
Inventory Turnover0.940.860.810.761.02
Yield & Distribution Ratios
Earnings Yield-0.07%-0.17%-0.18%-0.13%-0.09%
FCF Yield-0.06%-0.12%-0.15%-0.11%-0.07%
Buyback Yield-0.17%-0.14%-0.10%-0.15%-0.15%